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Key messages:  
Citizen science and participatory research have become hot topics in various areas of biomedical 
research. 
Although citizen science and participatory practices have been used successfully in a few instances 
within epidemiological research, the role they could play in this field has not been explored suffi-
ciently. 
This editorial proposes a model for an innovative use of citizen science in epidemiology called ‘Eve-
ry participant is a PI’ (EPPI). 
EPPI involves the creation of a non-profit citizen association of research participants to contribute to, 
and govern, a repository of samples and data for epidemiological research.  
In describing EPPI, this editorial aims to further a discussion about the potential of citizen science 
and participatory research for the field of epidemiology. 
 
Editorial 
EVERY PARTICIPANT IS A PI: CITIZEN SCIENCE AND PARTICIPATORY 
GOVERNANCE IN POPULATION STUDIES 
 
Background: Declining participation in population research 
The willingness of people to participate in population-based studies has been declining for 
decades and is likely to continue to do so (1,2). Recently, large-scale cohort studies even had 
to be aborted due to poor recruitment (3). Although the use of online tools can boost recruit-
ment in some contexts, attrition remains a big problem for such studies (4,5).  
 
This situation is deeply concerning for epidemiological research. The effects of poor recruit-
ment and high attrition are poor statistical power and an exacerbation of selection bias, which 
in turn diminishes the representativeness of population-based samples. For example, the dis-
proportionate reduction in participation of people with low socioeconomic status (SES) could 
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have significant impact on the validity of study results, since one of the most robust findings 
of contemporary epidemiology is the association between low SES and disease risks (6). Un-
fortunately, recruiting participants for population studies from marginal or vulnerable groups 
seems particularly difficult (3). 
 
According to Galea and Tracy (7), there are four structural drivers of decline in research par-
ticipation, all of which are difficult to address by those currently planning large and long-
term cohort studies: an escalation of the numbers of studies conducted; public mistrust in 
research; studies have become more burdensome for participants; and a general decrease in 
volunteerism in Western countries.  
 
Can participatory methods help? Citizen science in population research 
Recent patient- or participant-centered governance approaches to biobanking, whilst mostly 
focussing on matching consent and data protection requirements to the practical realities of 
population-based research, could also be seen as initiatives that focus on engaging partici-
pants more directly to increase initial sign-up and decrease attrition (8). We suggest a bolder 
approach, namely the introduction of so-called citizen science or participatory research strat-
egies into population research. This would involve the transfer of more control over research 
agenda setting as well as the usage and handling of data and samples to participants. It could 
facilitate more meaningful engagement of people with the information that they contribute to 
research projects and the project as a whole, and enhance the volume and persistence of par-
ticipation in well-designed epidemiological and biomedical studies. 
 
What are citizen science and participatory research? 
Digital technologies have already made it much easier for people without professional train-
ing to contribute to research (9). So-called ‘citizen science’ practices can take many forms, 
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including data and sample collection, data coding and analysis, and problem solving (10). 
And indeed, a quickly growing number of online platforms facilitate and involve contribu-
tions from lay people, generating biomedical datasets or enrolling volunteers to help with 
data analysis (11). 
‘Citizen science’ is a broad church. It has origins in various fields and so far, the term de-
scribes a still emerging, heterogeneous field encompassing a broad range of activities (12,13). 
This is also reflected in the fact that the terms ‘citizen science’, ‘participatory research’ as 
well as ‘patient-led research’ are often used synonymously (14). While there is no universal 
definition of the term, all initiatives associated with citizen science have one thing in com-
mon: They include participation from volunteers who are not professional researchers (15). 
Contributions from volunteers can range from data collection that individuals input into a 
project run by professional scientists, to serving as advisers in the design of clinical trials, to 
volunteers themselves developing and performing a study on a treatment for their own illness, 
for example via a patient social network (some of these may be non-profit, some for-profit, 
and, in turn, collaborate with, e.g. pharmaceutical companies) (11). In the absence of a sharp 
analytical category, for the purpose of this paper we use ‚citizen science’ as a broad label that 
includes all of these understandings. We use ‘participatory practices’ as a generic term to 
refer to contributions that people make within citizen science project.   
In biomedicine so far, most citizen science projects are run by professional scientists and re-
searchers, with lay participation in the form of voluntary data and sample donations, or finan-
cial contributions to data-rich projects (crowdfunding) (16). In these projects, decision-
making and research agenda setting largely rest with the researchers running the projects 
(they could be described as ‘top-down’ citizen science projects). However, interest is growing 
in initiatives where lay volunteers and patients take a more active role and function as part-
  
5 
ners in their own right in research initiatives, or truly lead on research direction and decision 
making (‘bottom-up’ citizen science projects).  
Some scholars have criticised citizen science, citing worries that due to lack of formal train-
ing, results might be of lower quality, or that such initiatives are vulnerable to commercial 
influences and interests, leading to biased results (17, 18). Certainly, not all participatory 
practices are created equal (11), but if done well, they could indeed provide a tool to support 
increased and meaningful participation of members of the public with science and research 
(16). User-friendly online tools and platforms in particular have expanded the ways in which 
individuals can control their data, paving the way for participant-centred initiatives in bio-
medicine and easing the dialogue between participants and researchers (19). Industry and 
policy makers have also devoted significant attention to these phenomena (22, 21, 22, 23). 
The sharply growing number of citizen science platforms and projects over recent years alone 
indicates that it draws in individuals and populations that might heretofore have not been in-
terested in research at all.  
 
So far, the role that citizen science and participatory practices could play in epidemiology has 
received limited attention. This is despite the fact that there are some successful initiatives of 
volunteers contributing epidemiologically relevant data, for example to detect epidemics fast-
er than traditional hospital-based monitoring and tracking systems. Notable cases include the 
European Influenzanet (24), the US-based Flu-near-you (25), and other ‘digital epidemiolo-
gy’ projects that provide local and timely information about disease dynamics in populations 
(26,27). Other examples include the harvesting of qualitative epidemiological intelligence 
contained, for example, within community observations and traditional oral history in veteri-
nary epidemiology (28). These projects rely on volunteer participation and provide proof of 
principle that lay contribution in epidemiology can have very meaningful results for, e.g., 
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public health. However, in terms of participation, such projects appear to be mostly organised 
in a top-down fashion, with the contribution of participants largely restricted to providing 
those running the projects with data; decision-making agency and control over the data and 
their further usage, as well as the direction of research, remain fully with those running the 
projects.  
We believe that a further step should be taken in participatory epidemiological research. Epi-
demiological datasets and biobanks offer an as of yet unexplored opportunity to incorporate 
citizen science initiatives that are far more bottom-up into epidemiology, with volunteers 
themselves actively driving and controlling research. In the following, we sketch out the idea 
of a participatory model for population research that could be able to provide individual con-
trol over personal data as well as impact on research agendas, create robust datasets for bio-
medical research, and potentially counteract the response decline discussed above, all at the 
same time: Every Participant is a Principle Investigator (EPPI). 
 
Every Participant is a PI (EPPI) 
We propose to trial the creation of a non-profit citizen association of voluntary participants to 
form a sample and data repository they have largely control over. The basic idea is similar to 
the idea of health data cooperatives (29) or open data repositories such as DNAland (30) or 
OpenHumans (31). However, the crucial difference to these lies in the governance structures.  
Unlike the other repositories, EPPI is not a repository where people simply deposit data from 
various sources. It is an initiative where the main reason it exists in the first place is so that 
people can join with the specific goal of creating a joint repository together. Participants 
would decide together what types of data would be collected, stored, and used, and by whom. 
To the best of our knowledge, this has never been done in epidemiology.  
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Recruitment for EPPI could proceed in the following way: After the selection of a first popu-
lation-representative sample, all potential participants would be informed about their selec-
tion and invited to participate in the EPPI project, and to form an association. To maximize 
the response, the invitation would be accompanied by regional and social media activities. 
The exact number of participants invited and the legal form of the EPPI association would 
depend on local circumstances and initial study aims, but in any case, membership would 
involve donation of samples and data into the EPPI repository. Should the final study popula-
tion not be sufficiently large enough to answer the study questions, the sample could be ex-
tended appropriately. All EPPI participants would be informed initially that in contrast to 
existing biobanks, data handling, research agenda setting, and governance would not be 
handed entirely over to a third party, such as a university or research institute, but that mem-
bers would remain involved in all of these processes if they so desire. Every participant 
would retain access to their own ‘raw’ data as it was entered into relevant databases in the 
cohort (32) and be able to participate in data governance. They could also propose study 
questions and secondary data uses. The central decision making body would be a governance 
board consisting entirely of participants. This board would appoint an advisory board that 
would include scientific and clinical experts.  
 
EPPI is underpinned by the idea of solidarity. Current understandings of solidarity frame it as 
practices that harness people’s willingness to help others (33). Such pro-social willingness to 
work towards a common goal has been shown empirically to be an important motivation to 
participate in cohort studies and other research endeavours (34,35). Current biobanking gov-
ernance frameworks, however, are not regularly reflective of solidarity-based motivations in 
participants, focusing instead on protecting individuals’ autonomy and shielding them from 
the risks of research (such as violations of privacy and data protection) (19). In EPPI, the sol-
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idaristic idea that participants engage in a common endeavour, joining an initiative in which 
they decide together what the direction of research and particular research goals should be, 
would be front and center and serve as a motivational incentive to participate. In this model, 
individual control of data at every step of the way, while one obvious feature, is not the over-
arching goal. Instead, the emphasis is on enhancing reciprocity between different actors in-
volved in research (i.e. between research participants, and participants and researchers), and 
further deliberation and genuine participation in the sense that people who do want to engage 
with decision making can do so. Further, mechanisms to ensure that people are not left alone 
when something does go wrong as part of this communal endeavour would be available (e.g. 
harm mitigation funds, 19,33).  
We believe harnessing pro-social motivations to participate in research in a more systematic 
way could counteract the effects of mistrust and decreasing interest in more ‘traditional’ 
forms of research mentioned above (7), and that EPPI would be a suitable form to test this 
hypothesis. We also think this idea is eminently suited to be explored in epidemiology: Un-
like, clinical medicine, epidemiology addresses health issues at group and societal level, and 
an EPPI initiative would allow for direct interaction, reciprocity and mutual support between 
members of a particular group. 
  
Practically, as described, an EPPI initiative could be recruited wholly afresh, as described, or 
it could tag onto existing cohorts. In any case, it would typically be initiated by research-
ers/biobankers (but in theory also by patients or other citizens with a specific idea). Partici-
pants of a large existing cohort, for example a large research biobank, could also be invited to 
form an association as described. The association could be formed early on, whilst actual 
sample deposition and testing etc. would depend on the capacity of the study centre and the 
study aims, and would likely happen over a period of time. At least in the beginning and in 
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view of the significant costs state of the art-biobanking involves, to get the ball rolling, facili-
ties for sample and data storage and handling would have to be made available by an institu-
tion that is later contracted by the association as service provider.  
 
If recruitment in the way described was successful enough to start an association and estab-
lish a governing body, researchers would be part of any advisory board that the governing 
body would appoint, but would not have any further powers of agenda setting. All significant 
decisions would be made by the governance board consisting of participants. Once the EPPI 
cohort recruited is large enough for research, the governing body would decide on future 
study topics; which additional facilities to involve in future research; whom to allow use of 
the data and to what end; how to utilise and disseminate research results; etc. Researchers all 
over the world could apply for data and biomaterial usage, and suggest specific kinds of data 
or samples being collected. The association would appear as main or co-applicant in project 
proposals, appear as co-author on publications, participate in meetings of research consortia 
that use data that are co-owned by members, and so on. An association has the key advantage 
that it would outlast single projects, thus being able to co-govern long-term longitudinal stud-
ies. Moreover such an association could tap into additional sources of funding – for instance 
crowdfunding, which is often combined with or part of citizen science initiatives (36,16). 
 
EPPI governance 
This idea might sound very unusual in view of the way existing research cohorts are gov-
erned (for an overview of the differences between established governance models and EPPI, 
see Table 1). However, there are already templates and precedents for specific elements of 
such an initiative. Models are in place that allow for individual control over data (37), and 
there have been prominent examples of successful patient-led research (38). It has also been 
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shown that participants can make productive as well as consumptive use of research(39). For 
example, the platform PatientsLikeMe, a social network for patients whose business model 
includes selling patient data to companies has facilitated the initiation of clinical studies by 
patients, for instance in the case of a study on the effects of lithium on the progression of am-
yotrophic lateral sclerosis (40). The extent to which such initiatives put patients and other 
citizens in control of research can be debated, but there is little doubt that they illustrate the 
interest of participants to engage more directly with research that could usefully be exploited 
to counteract the disenchantment with more ‘traditional’ forms of research mentioned above. 
 
So far, the two objectives of data control and impact on research agenda setting, which would 
be joined in EPPI initiatives, have rarely been pursued together. Participant-centred govern-
ance of health datasets and biobanks has been typically understood as an extension and deep-
ening of individual control over personal data and biological material on the basis of concerns 
for the autonomy and safety of participants (37). While such forms of governance may some-
times have an impact on how research is conducted and whether participants can influence 
research questions, planning and executions on the basis of their values and interests, such 
impact is mostly a side-effect, and not the main aim, of such models. In addition, fostering 
collective decision-making and deliberation certainly does not play a role in such governance. 
Here, we propose to go beyond individual and autonomy-based solutions and instead employ 
a governance approach that explicitly aims at opening up spaces where participants can put 
forward their ideas, research questions and concerns and deliberate them together. This may 
require broadly extending the understanding of participants’ roles in research.  
 
 
XXX Table 1 here XXX 




Precursers and potential advantages 
While the devolvement of control and agency in EPPI will probably be regarded as a radical 
intervention by many, to our mind EPPI is no more than the next logical step in the trend to 
engage and involve patients and citizens in biomedical research in more active ways – alt-
hough admittedly, it would be a large step and one that has not yet been taken in epidemiolo-
gy (see table 2 for relevant differences between previous types of participatory initiatives 
relevant in epidemiology, and EPPI).  
The implementation of participant-led features in contemporary epidemiological research 
continues a long standing tradition of popular epidemiology (41), whereby “lay” participants 
engage with scientists to tackle local issues and/or issues of concerns of those communities 
whose needs are often overlooked by traditional forms of research agenda setting (42). It is 
also an experience very much in line with one important early meaning of “citizen science” 
(43) and “science shops”, which – rather than denying the saliency of the different types of 
expertise of formally qualified scientists and citizens – tried to open up spaces where citizens 
could voice their priorities, concerns, and ideas and channel them into the mechanisms of 
agenda setting of science. 
 
xxx Table2 here xxx 
 
 
However, EPPI could not only learn from other citizen science initiatives, including those in 
other fields. It could also benefit from another important precursor: the Patient and Public 
Involvement movement (PPI) (44, 45). Efforts to include the patient perspective more explic-
itly in research – e.g. in clinical trial planning – have been pursued for some time now, and 
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are well documented (46, 47). EPPI could learn from and be informed by these experiences. 
For example, patients’ and citizens´ roles in PPI are often framed or understood in terms of 
‚public consultation’ (48). This has led to concerns that such forms of lay participation might 
pitch the ‘public view’ vs. the ‘scientific view’, rather than steering the research agenda in 
directions agreed upon by professional scientists and lay citizens alike (49). We argue that 
because volunteers would steer the direction of research very actively in EPPI, it could 
breach this dichotomy. Moreover, PPI has been shown to be most relevant at the design stage 
of research (50), and the governance body of EPPI that would decide on this stage, made up 
of participants, is a central element of our proposed idea. 
 
We believe that an EPPI initiative that was informed by previous, related experiences but 
pushed ahead of these, chartering new waters, could help reverse the aforementioned trends 
that drive declining participation rates in population-based research. As mentioned, tradition-
al volunteerism is declining, but new form of sociality are developing at the same time, and 
benefiting from communication technologies. These can and should be fruitfully exploited by 
health researchers. Sharing personal medical data for the sake of research (either for curiosi-
ty, concern for a particular medical condition that affects the donor, or pro-social reasons) is 
becoming common, and especially among communities of citizens who seek to understand 
and tinker with their genomic data (51, 52). The empowerment of participants intrinsic in an 
EPPI initiative may also help address mistrust in biomedical science, and avoid the feeling of 
participants that they are being experimented upon as they learn about, intervene and ulti-
mately decide about the research process. If successful, an EPPI initiative could eventually 
motivate people to participate, promote recruitment and retention, and cut attrition. At the 
very least, such an expectation, seen against the background of the emerging field of citizen 




In a system where participants are also co-investigators, some ethical issues and problems 
would fade into the background, as participants would overall be less in need of protection 
against third parties with competing interests (researchers, companies etc.), being themselves 
part of the governing bodies of research (53). Moreover, as mentioned above, the debate 
around novel forms of informed consent has brought attention to the fact that consent can 
also be seen as a form of consent to an entire system of governance, rather than to any single 
research initiative (54). In view of these considerations, it is at least likely that the more ro-
bust participatory features of an EPPI initiative would impinge positively on the perceived 
legitimacy of research, although this would have to be tested empirically in future EPPI stud-
ies. 
 
Potential pitfalls and challenges of the EPPI model 
Like every new idea, EPPI comes with a number of potential drawbacks and challenges, 
some of which can be anticipated, whilst others will only emerge in the pilot phase of such a 
project, or even at later stages.  
Concerns that lack of training or experiences would lower the quality of results we believe 
could be assuaged by having an advisory board comprised of epidemiologists, biobanking 
experts and other researchers with relevant expertise, and by running EPPI, at least initially, 
on established IT, data and sample management infrastructure of existing cohorts.  
However, another issue is possibly more difficult to avoid: PPI scholars have pointed out that 
projects of this kind can be vulnerable to ‘hijacking’, for example from highly educated indi-
viduals with professional and managerial backgrounds (55). Moreover, in the case of EPPI, 
researchers – and even executives from companies interested in cohort data – could become 
members and try to access collective data sets for their own work, as well as try to gain influ-
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ence over agenda setting and decision making as part of the governing body. Similarly, the 
EPPI project overall, or the governance board more specifically, could become dominated by 
small groups of volunteer participants, or individuals with particular interests, that are espe-
cially vocal and engaged. This could lead to potential tensions within the EPPI association, as 
well as to unrealistic study aims, for example if individuals with very rare illnesses came to 
dominate the discussion, e.g. by demanding a study to assess the prevalence or incidence of 
that disease.  
These are serious concerns, but we believe they can be addressed. In order to avoid any form 
of hijacking, EPPI would require well-designed policies for membership conduct, which 
would likely include high transparency regarding a member’s potential conflicts of interest. 
Strategies and mechanisms of mediation would also have to be developed and implemented 
as part of the governance structures right from the start. To develop effective policies to this 
effect jointly, within a governing body made up of participants, is certainly a challenge. On 
the other hand, hijacking is not a problem exclusive to EPPI, and there are many policy ex-
amples for disclosing conflicts of interest, medication, etc. that EPPI could learn from. 
It could be assumed that because EPPI research – just as other forms of population-based 
research – is not organised around specific diseases, it could lack the enthusiasm and en-
gagement that can be observed in some citizen science projects, where research is driven by 
patients with very immediate needs. This could mean that, particularly in societies where 
individualistic values are strong, EPPI initiatives would not encounter much interest.  
There is no doubt that initiatives that aim to combat particular diseases and develop treat-
ments will be attractive to patients with that illness. However, many current citizen science 
initiatives, some of which are quite substantive in terms of the number of those involved, do 
not focus on particular diseases. In fact, a substantial number of citizen science projects takes 
place outside of the biomedical realm, and they attract substantive numbers of participation 
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(14), for example in several of the projects hosted in the platform Zooniverse (56). Moreover, 
the emerging forms of medical participatory research on online social platforms, e.g., eluci-
date a desire of citizens to have more direct involvement with research in general. If done 
well, citizen science can thus respond to citizens’ desire to be more engaged with and con-
tribute to science. Moreover EPPI would, in addition to previous initiatives, devolve signifi-
cant control over the whole research process to participants, and this could open up new areas 
of interest for the subset of citizens already interested in participatory and voluntary initia-
tives. Whether appealing to all these interests and motives would be sufficient to recruit 
broad enough samples for EPPI initiatives to flourish needs to be tested in practice. 
 
Another potential challenge EPPI shares with established forms of population research is to 
engage participants from marginalised groups and with lower socioeconomic status. Current 
recruiting strategies struggle to overcome barriers to accessing population-based research, 
and there is reluctance to participate originating, for example, in distrust (57, 58). This is also 
a well-described problem for PPI initiatives, even where PPIs exercises exist that are explicit-
ly designed to reach minorities (48).  
An EPPI initiative starting with a recruiting drive in an established cohort could utilise all the 
emerging online recruiting strategies available, and this might already contribute to engaging 
minorities and groups that heretofore have not been interested in research and who dropped 
out, or declined participation, in existing cohort studies. In addition, however, and in contrast 
to more traditional population-based research, EPPI could address the distrust that arguably 
plays a role in the difficulties to engage marginalised groups, and this could improve partici-
pation from these groups, once EPPI recruited outside the pre-existing cohort. EPPI explicitly 
devolves control over the research to participants and this could motivate those usually dis-
trustful of research endeavours to participate.  
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We believe that this expectation that EPPI initiatives could reach yet under-represented popu-
lations is reasonable (59). EPPI initiatives could also, with online recruitment strategies as 
well as with participant-led, oral recruitment within local communities, help overcome well-
known literacy problems that traditional population-based research suffers from.  
 
There are also obviously different kinds of costs that such an experiment would incur. Setting 
up infrastructures for inclusive governance in an EPPI initiative, and for people to have ac-
cess to their own raw data, will require significant resources. However, there is currently sig-
nificant interest by funders to support citizen science and participatory initiatives, and this 
could mean additional streams of resources for the early stages of such initiatives. And, if the 
EPPI experiment was successful and provided a ‘proof of principle’ for bottom-up epidemio-
logical citizen science, it would not be unreasonable to expect that such projects could even-
tually become financially self-sustaining, or at least considerably cheaper. They could draw 
in funding from those interested in the materials and data the association has control over. 
 
Conclusions 
We expect that there might be other criticisms that could be levelled against this idea, and 
indeed we urge colleagues in the field to raise any concerns we have not anticipated in this 
editorial, so that the idea of an EPPI pilot can be refined. It is our explicit aim, by offering the 
idea of EPPI to the epidemiology community, to start a discussion about the future potential 
of this type of bottom-up citizen science in epidemiology. We believe that this potential is 
indeed significant, and that citizen science applications and participatory research and gov-
ernance strategies could lead into a novel area to explore for the field. And, in any case: if we 
do not experiment with such initiatives, we will never be able to assess their real benefit, via-
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